DAPXIGA 5MG TABLET

Dapxiga 5mg tablet contains dapagliflozin, which is an oral medication used for the management of type 2 diabetes mellitus. It belongs to the class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Dapagliflozin works by reducing the reabsorption of glucose in the kidneys, thereby lowering blood glucose levels.

Uses:

1. Type 2 Diabetes Mellitus: Dapxiga 5mg tablet is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels by increasing the excretion of glucose through urine.

Side Effects:

1. Genital Infections: Dapagliflozin may increase the risk of genital infections, such as yeast infections in females and balanitis in males. Symptoms may include itching, redness, discharge, or pain in the genital area. Good hygiene practices and prompt medical attention are recommended if such infections occur.
2. Urinary Tract Infections: Some individuals may experience urinary tract infections while taking Dapxiga 5mg tablet. Symptoms may include frequent urination, pain or burning during urination, and cloudy or bloody urine. Drinking plenty of fluids and seeking medical attention if symptoms persist is important.
3. Increased Urination and Thirst: Dapagliflozin can cause an increase in urine production and subsequently increased thirst. It is important to stay hydrated and drink sufficient fluids throughout the day.
4. Hypoglycemia: When used in combination with other antidiabetic medications like insulin or sulfonylureas, Dapxiga 5mg tablet may increase the risk of hypoglycemia (low blood sugar). Close monitoring of blood sugar levels is essential, especially during dose adjustments or when combining with other medications.

When Not to Use:

1. Type 1 Diabetes: Dapxiga 5mg tablet is not indicated for the treatment of type 1 diabetes mellitus.
2. Diabetic Ketoacidosis: Dapagliflozin should not be used in individuals with diabetic ketoacidosis, a potentially life-threatening condition characterized by high blood sugar and ketone production.
3. Severe Renal Impairment or End-Stage Renal Disease: Dapxiga 5mg tablet is contraindicated in individuals with severe renal impairment or end-stage renal disease, as it may further deteriorate kidney function.
4. Hypersensitivity: Individuals with a known hypersensitivity or allergy to dapagliflozin or any components of Dapxiga 5mg tablet should not use this medication.
5. Pregnancy and Breastfeeding: The safety of dapagliflozin during pregnancy and breastfeeding is not well established. It is advisable to consult a healthcare professional before using this medication in these situations.

Note: This is a general overview of Dapxiga 5mg tablet (dapagliflozin), and it is important to consult a healthcare professional for specific information regarding your condition and individual circumstances.